shortagewatch

Home / Companies / GSK

Company family · HQ GB

GSK: medicine shortages

GSK · LSE

As of 2 Nov 2026, 85 GSK products have a reported shortage across 12 countries, covering 38 medicines.

Products short85rank #22 of 464
Medicines38active ingredients
Countries12/16
New in 90 days37+6 vs market pace
Typical duration3 monthsmedian so far
Manufacturing35%demand-driven 43%

Where

United States3Canada6Italy17Spain5Ireland5Austria8Belgium7Switzerland6Czechia7Norway11Sweden8Japan2

Which therapeutic classes

Anti-infectives34Respiratory system22Nervous system13Dermatologicals6Antiparasitics4Genito-urinary system and sex hormones2Sensory organs1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
GSKGSK: Manufacturing problem 22 (27%)27%GSK: Increased demand 27 (33%)33%GSK: Active ingredient shortage 1 (1%)GSK: Distribution or logistics 3 (4%)GSK: Commercial decision or withdrawal 3 (4%)GSK: Other 5 (6%)6%GSK: Not stated 22 (27%)27%All companiesAll companies: Manufacturing problem 4,896 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,220 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes
DateCountryMedicineChange
2 NovBESalbutamol
Ventolin 1 mg/ml inf. sol. (conc.) i.v. amp. 5 x 5 ml		new shortage (back 27 Nov)

Open shortages over time

3536373831 Oct2026-10-31: 361 Nov2026-11-01: 362 Nov2026-11-02: 37

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 1May: 1MayJun: 1Jul: 1Aug: 1AugSep: 0Oct: 1Nov: 0NovDec: 2Jan ’26: 3Feb: 1FebMar: 1Apr: 1May: 2MayJun: 2Jul: 10Aug: 10AugSep: 13Oct: 14Nov: 2Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 5220172018: 4320182019: 3420192020: 3320202021: 4420212022: 6020222023: 4220232024: 2920242025: 3720252026: 92026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz603Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158GSK85

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 603 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 150 / 73Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7GSK: 85 / 38GSK

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Sumatriptan820 May 2026Manufacturing problem13/16
Salmeterol and Fluticasone527 Jul 2026Not stated6/16
Hepatitis A, Inactivated, Whole Virus429 Jun 2026Increased demand4/16
Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated41 Jan 2019Manufacturing problem3/16
Salbutamol41 Jul 2024Manufacturing problem6/16
Salmeterol422 Sep 2026Not stated2/16
Albendazole313 Jun 2025Distribution or logistics5/16
Betamethasone39 Nov 2026Manufacturing problem4/16
Diphtheria-Pertussis-Poliomyelitis-Tetanus310 Jul 2025Increased demand4/16
Valaciclovir326 May 2025Increased demand10/16
Varicella, Live Attenuated39 Dec 2025Not stated3/16
Aciclovir217 Aug 2026Increased demand6/16
Combinations214 Aug 2026Not stated2/16
Hepatitis B, Purified Antigen227 Aug 2026Increased demand3/16
Lamotrigine22 Oct 2026Increased demand9/16
Measles, Combinations with Mumps and Rubella, Live Attenuated223 May 2023Increased demand2/16
Mepolizumab219 Oct 2026Manufacturing problem2/16
Paroxetine230 Apr 2026Manufacturing problem8/16
Pertussis, Purified Antigen, Combinations with Toxoids219 Jan 2026Increased demand3/16
Tamsulosin and Dutasteride228 Aug 2026Increased demand3/16
Vilanterol and Fluticasone Furoate26 Aug 2026Other1/16
Zoster, Purified Antigen222 Oct 2025Increased demand2/16
Aciclovir16 Mar 2024Quality problem or recall2/16
Clindamycin, Combinations19 Oct 2026Manufacturing problem3/16
Clobetasol127 Nov 2026Not stated2/16
Codeine, Combinations excl. Psycholeptics15 Jul 2021Manufacturing problem1/16
Fluticasone123 Nov 2026Increased demand2/16
Hydrocortisone Butyrate112 Oct 2026Increased demand1/16
Influenza, Inactivated, Split Virus Or Surface Antigen120 Sep 2026Not stated4/16
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated128 Sep 2026Increased demand3/16
Meningococcus B, Multicomponent Vaccine127 Aug 2026Manufacturing problem1/16
Mupirocin119 Oct 2026Quality problem or recall1/16
Opium Derivatives and Expectorants11 Jun 2023Other2/16
Proguanil and Atovaquone17 Sep 2026Increased demand6/16
Respiratory Syncytial Virus Vaccines11 Oct 2026Commercial decision or withdrawal1/16
Rota Virus, Live Attenuated11 Aug 2025Not stated1/16
Salbutamol12 Nov 2026Manufacturing problem1/16
Umeclidinium Bromide120 Oct 2026Manufacturing problem1/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.